| HOME >> BIOLOGY >> TECHNOLOGY |
Repayment of long-term debt (152,546) (183,969)
Proceeds from long-term debt 634,900 -
Repayment of repayable advances - (85,640)
------------ ------------
Cash provided by financing activities 456,220 14,282,840
------------ ------------
------------ ------------
Investing activities
Acquisition of property and equipment (544,844) (444,816)
------------ ------------
Cash used in investing activities (544,844) (444,816)
------------ ------------
------------ ------------
Increase (decrease) in cash and cash
equivalents (4,159,235) 12,477,478
Cash and cash equivalents - Beginning of
period 20,444,013 16,328,459
------------ ------------
------------ ------------
Cash and cash equivalents - End of period 16,284,778 28,805,937
------------ ------------
------------ ------------
Supplemental Information
Cash interest received 100,607 603,639
Cash interest paid 28,755 51,422
Non-cash transactions
Capital items included in accounts
payable 112,838 469,161
Share issue costs include
'/>"/>
| SOURCE SemBioSys Genetics Inc. Copyright©2008 PR Newswire. All rights reserved |